Innovation is at the heart of Straumann’s success, from developing groundbreaking materials and technologies to finding new and better ways to add value for customers and patients – beyond products and technological solutions.
We held to our commitment of maintaining our investments in R&D and clinical excellence – despite the more challenging economic circumstances and pressure on profits. Consequently, R&D investments rose to 7% of revenue.
|Roxolid||Higher strength; improved bioresponse|
|SLActive (Japan)||Faster healing; higher security|
|Less invasive implant bone||Treat cases with severely reduced bone
|Ceramic implant||Tooth-color for high-end esthetics|
|Implant maintenance||TiBrush to rescue implants|
|Soft tissue control||Tissue control around implants|
|Implant anchor for overdentures||Greater angulation and flexibility|
|CARES 8.0||Standardization of digital workflows; CARES workflow for external options|
|CARES Scan & Shape||Enhanced access to digital workflows|
|Improved temporary restorations||Easier chairside preparation|
|New CADCA M abutment solutions||More options for implant restorations|
|New materials for restorations||Improved handling|
|PEG technology||More applications|
|Enhanced bone graft material||Enhanced bone regeneration|